Form 8-K - Current report:
SEC Accession No. 0000950170-25-086215
Filing Date
2025-06-13
Accepted
2025-06-13 16:21:19
Documents
10
Period of Report
2025-06-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sldb-20250612.htm   iXBRL 8-K 73436
  Complete submission text file 0000950170-25-086215.txt   177658

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sldb-20250612.xsd EX-101.SCH 23888
12 EXTRACTED XBRL INSTANCE DOCUMENT sldb-20250612_htm.xml XML 4528
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Filer) CIK: 0001707502 (see all company filings)

EIN.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38360 | Film No.: 251046894
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)